CD274 and neoplasm: In epithelial-derived malignancies, PD-L1 expression is associated with poor prognosis, regardless of the antibody used and the assessed cutoff values (Ghebeh et al., 2006; Thompson et al., 2006; Thompson et al., 2007), consistent with its role as a suppressor of tumor immunity.